Company Filing History:
Years Active: 2017
Title: Rick Rinck: Innovator in Pharmaceutical Peptides
Introduction
Rick Rinck is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides. His work focuses on the Angiotensin type 2 (AT2) receptor, which plays a crucial role in various physiological processes.
Latest Patents
Rick Rinck holds a patent for "Angiotensin type 2 (AT2) receptor agonists and uses thereof." This invention relates to novel pharmaceutically useful peptides, specifically cyclic peptides that act as agonists of the AngII type 2 receptor. The patent further details the use of these peptides as medicaments, the pharmaceutical compositions containing them, and their production methods. He has 1 patent to his name.
Career Highlights
Rick Rinck is associated with Lanthiopep B.V., a company that specializes in the development of peptide-based therapeutics. His work at Lanthiopep has positioned him as a key player in the pharmaceutical industry, contributing to advancements in drug development.
Collaborations
Rick collaborates with talented individuals such as Louwe De Vries and Sieger Adriaan Nelemans. Their combined expertise enhances the innovative capabilities of their projects.
Conclusion
Rick Rinck's contributions to the field of pharmaceutical peptides demonstrate his commitment to advancing medical science. His innovative work continues to impact the development of new therapeutic options.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.